查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1835064

不孕症檢測市場（按類型、產品、技術和最終用戶）—2025-2032 年全球預測

Fertility Testing Market by Type, Product, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，不孕症檢測市場規模將成長至 7.7028 億美元，複合年成長率為 9.13%。

主要市場統計數據
基準年2024年 3.829億美元
預計2025年 4.176億美元
預測年份：2032年 7.7028億美元
複合年成長率（%） 9.13%

策略入門，重點介紹臨床需求、消費者主導的診斷、技術融合以及影響不孕症檢測的商業化優先事項

不孕症檢測領域是一個複雜的生態系統，臨床需求、消費者賦能和快速的技術進步交織在一起，需要清晰的思路和策略遠見。臨床醫生和診斷實驗室正在探索新的患者診療路徑，而個人也擴大獲得複雜的居家診斷服務。同時，產品創新者正在將實驗室級分析與以用戶為中心的數位體驗相結合，以重塑生育健康的評估、追蹤和應對方式。

本執行摘要概述了關鍵趨勢及其對整個價值鏈相關人員的實際影響。它強調了照護現場方法的不斷發展、孕前保健中基因篩檢服務的日益成熟，以及數位診斷在將生物訊號轉化為可操作指導方面日益成長的影響力。它還揭示了監管變化、報銷爭議和付款人審查如何影響臨床應用和商業策略。

本概述透過臨床路徑、技術賦能因素和最終用戶期望來建立當前環境，為明智的決策奠定基礎。領導者可以找到有助於確定投資優先順序的背景訊息，識別營運漏洞，並發掘夥伴關係機會，從而在保持臨床嚴謹性和品質保證的同時，加速接觸高價值患者群體。

技術融合、患者主導的數位化應用以及不斷發展的法律規範如何重新定義不孕症檢測生態系統

不孕症檢測領域正在經歷變革時期，這得益於消費醫療技術與臨床診斷技術的整合。數位化檢測套組和可重複使用的監測解決方案增強了縱向追蹤能力，而酵素結合免疫吸附檢測法和數位成像等實驗室檢測法則繼續為複雜的荷爾蒙和基因評估提供分析支撐。這種技術互補性正在催生混合護理模式，即診所檢測、參考實驗室分析和家庭監測並存，從而提供更豐富的臨床資訊。

同時，患者行為也在不斷演變。人們尋求更早、更頻繁、更個人化的生殖健康洞察，這推動了直接面對消費者和臨床醫生輔助的居家檢測項目的成長。這種需求推動了對使用者體驗、遠端醫療整合和數據互通性的投資，以確保檢測結果反映在護理路徑中並支援共用決策。監管機構正在更新指南，以平衡可及性、分析效度和適當臨床解讀的需求，從而影響產品設計和商業化時間表。

最後，隨著醫療服務提供者和供應商探索配套服務、訂閱監控和結果主導定價，以協調相關人員之間的獎勵機制，商業模式也在改變。這些動態預示著未來不孕症檢測將更加連續、數位化，並融入更廣泛的生殖健康進程。

評估累積關稅變化將如何影響生育診斷供應鏈的彈性、籌資策略、臨床可及性和產品設計

影響診斷組件和成品設備的關稅波動可能會改變不孕症檢測相關人員的供應鏈經濟狀況、籌資策略和上市時間動態。進口試劑、感測器和某些電子元件的關稅上調可能會增加診所平台和家用檢測套組的單位成本，迫使製造商和經銷商重新評估籌資策略和合約條款。為此，許多公司正在考慮組裝組裝、篩選合格的替代供應商，並重新設計產品物料材料清單，以減少關稅敏感內容。

在營運方面，關稅可能會延長前置作業時間，並擾亂就地檢驗服務和參考實驗室的庫存規劃，因為清關和合規檢查更加複雜。這種延誤可能會增加關鍵試劑和耗材的安全庫存，從而增加營運資金。從臨床可及性的角度來看，成本壓力可能會影響與付款人和醫院系統的定價和報銷談判，也可能推遲採用更新、高成本的診斷方法，直到其價值提案得到明確論證。

從策略角度來看，關稅正在加速供應商整合，並提升合約彈性的重要性。採購團隊更重視總到岸成本分析、關稅減免條款和多方採購安排，以維持服務水準。同時，採用模組化設計和軟體主導差異化策略的公司或許能夠更好地吸收離散成本衝擊，同時又不損害臨床報告品質和病患體驗。

詳細的細分分析揭示了測試類型、產品管道、檢測技術和最終用戶採用情況的需求促進因素

細分揭示了測試形式、產品管道、檢測技術和最終用戶的不同需求促進因素和營運考慮。基於類型的測試管道包括用於監測內分泌狀態的荷爾蒙測試、用於確定受孕窗口的排卵測試、用於確認受孕的懷孕測試以及用於評估男性不孕參數的精子品質測試。這些針對特定產品類型的專業測試在分析複雜性和臨床解讀方面各不相同，從而導致產品和服務需求的多樣化。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 人工智慧驅動的荷爾蒙分析平台在個人化生育能力評估的應用日益增多
  • 擴展與數位健康平台整合的綜合家用不孕不育檢測套組
  • 人們對男性不孕因素的認知不斷提高，推動了對男性不孕症檢測解決方案的需求激增
  • 將基因篩檢和孕前帶因者檢測整合到標準不孕症治療檢測中
  • 微生物組分析測試的出現，有助於評估生殖健康和最佳化生育能力
  • 引入遠距不孕症治療諮詢與家庭檢體採集服務結合
  • 開發穿戴式生物感測器設備，用於在懷孕週期內持續監測激素
  • 基於區塊鏈的資料安全解決方案確保直接面對消費者的生育測試的隱私
  • 加強生育診所與數位治療提供者之間的合作，提供全面的護理
  • 簡化創新不孕症診斷技術核准流程的監管變化

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章不孕症檢測市場（按類型）

  • 荷爾蒙測試
  • 排卵測試
  • 妊娠試驗
  • 精子品質測試

第9章不孕症檢測市場（按產品）

  • 基於臨床的檢測
    • 荷爾蒙面板測試
    • 在診所進行排卵測試
    • 診所的妊娠測試
  • 基因檢測
    • 攜帶者篩檢
    • 懷孕前基因檢測
  • 家庭檢測套組
    • 數位測試套件
    • 可重複使用的監視器套件
    • 試紙測試套件
  • 化驗服務
    • 就地檢驗服務
    • 參考化驗服務

第10章 不孕症檢測市場（依技術）

  • 數位影像
  • 酵素結合免疫吸附試驗
  • 側流免疫檢測

第 11 章不孕症檢測市場（依最終用戶）

  • 診斷實驗室
  • 不孕不育診所
  • 醫院
  • 個人

第12章不孕症檢測市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章不孕症檢測市場（按群體）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 不孕症檢測市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • The Procter & Gamble Company
    • F. Hoffmann-La Roche AG
    • CooperSurgical, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • QIAGEN NV
    • Abbott Laboratories
Product Code: MRR-4348D129FB2F

The Fertility Testing Market is projected to grow by USD 770.28 million at a CAGR of 9.13% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 382.90 million
Estimated Year [2025] USD 417.60 million
Forecast Year [2032] USD 770.28 million
CAGR (%) 9.13%

A strategic primer illuminating clinical demand, consumer-driven diagnostics, technological convergence, and commercialization priorities shaping fertility testing

The fertility testing landscape sits at the intersection of clinical demand, consumer empowerment, and rapid technology advancement, creating a complex ecosystem that requires clarity and strategic foresight. Clinical practitioners and diagnostic laboratories are navigating new patient pathways while individuals are accessing increasingly sophisticated home diagnostics. Concurrently, product innovators are converging laboratory-grade analytics with user-centric digital experiences, reshaping how fertility health is assessed, tracked, and acted upon.

This executive summary synthesizes core trends and practical implications for stakeholders across the value chain. It emphasizes the evolving role of point-of-care modalities, the maturation of genetic screening services in preconception care, and the expanding influence of digital diagnostics that translate biological signals into actionable guidance. Moreover, the narrative highlights how regulatory shifts, reimbursement conversations, and payer scrutiny are influencing clinical adoption and commercial strategies.

By framing the current environment through clinical pathways, technology enablers, and end-user expectations, the overview provides a foundation for informed decision-making. Leaders will find context that supports prioritization of investments, identifies operational vulnerabilities, and surfaces partnership opportunities that accelerate access to high-value patient segments while maintaining clinical rigor and quality assurance.

How technological convergence, patient-driven digital adoption, and evolving regulatory frameworks are redefining the fertility testing ecosystem

The landscape of fertility testing is undergoing transformative shifts driven by convergence between consumer health technology and clinical diagnostics. Digital test kits and reusable monitor solutions are enhancing longitudinal tracking capabilities, while laboratory-based assays such as enzyme linked immunosorbent assays and digital imaging continue to provide the analytical backbone for complex hormone and genetic evaluations. This technological complementarity is enabling hybrid care models where in-clinic testing, reference laboratory analytics, and at-home monitoring coexist to deliver richer clinical narratives.

Simultaneously, patient behavior is evolving; individuals are seeking earlier, more frequent, and more personalized insights into reproductive health, prompting growth in both direct-to-consumer offerings and clinician-mediated home testing programs. This demand is reinforcing investments in user experience, telehealth integration, and data interoperability so that test results can feed care pathways and support shared decision-making. Regulatory bodies are responding with updated guidance that balances accessibility with the need for analytical validity and appropriate clinical interpretation, which in turn is shaping product design and commercialization timelines.

Finally, commercial models are shifting as providers and suppliers explore bundled services, subscription monitoring, and outcome-driven pricing to align incentives across stakeholders. These dynamics collectively point toward a future where fertility testing is more continuous, digitally enabled, and integrated into broader reproductive health journeys.

Assessment of how cumulative tariff shifts influence supply chain resilience, procurement strategy, clinical access, and product design across fertility diagnostics

Tariff changes affecting diagnostics components and finished devices can alter supply chain economics, procurement strategies, and time-to-market dynamics for fertility testing stakeholders. Cumulatively, increased duties on imported reagents, sensors, and certain electronic components have the potential to raise unit costs for both clinic-based platforms and home test kits, prompting manufacturers and distributors to reassess sourcing strategies and contract terms. In response, many companies consider nearshoring assembly, qualifying alternate suppliers, and redesigning product bills of materials to reduce tariff-sensitive content.

Operationally, tariffs can extend lead times as customs clearance and compliance checks become more complex, which may disrupt inventory planning for point-of-care testing services and reference labs. These delays incentivize higher safety stocks for critical reagents and consumables, thereby increasing working capital requirements. From a clinical access perspective, cost pressures could influence pricing and reimbursement negotiations with payers and hospital systems, and could also slow the adoption cadence for newer, higher-cost diagnostic modalities until value propositions are clearly demonstrated.

Strategically, tariffs accelerate supplier consolidation conversations and increase the importance of contractual agility. Procurement teams are placing greater emphasis on total landed cost analysis, tariff mitigation clauses, and multi-sourcing arrangements to maintain service levels. At the same time, companies with modular designs and software-driven differentiation may be better positioned to absorb discrete cost shocks without compromising the quality of clinical reporting or patient experience.

Deep segmentation analysis revealing distinct demand drivers across test types, product channels, assay technologies, and end-user adoption profiles

Segmentation reveals distinct demand drivers and operational considerations across testing formats, product channels, technologies, and end users. Based on type, testing pathways encompass hormone tests that monitor endocrine status, ovulation tests that pinpoint fertile windows, pregnancy tests that confirm conception, and sperm quality tests that evaluate male fertility parameters. These type-specific assays differ in analytical complexity and clinical interpretation, leading to divergent product and service requirements.

Based on product, the market spans clinic-based tests, genetic tests, home test kits, and lab services. Clinic-based tests include hormone panel assays, in-clinic ovulation diagnostics, and in-clinic pregnancy confirmation services that rely on trained personnel and integrated clinical workflows. Genetic tests cover carrier screening and preconception genetic assessments that demand high analytical accuracy and robust counseling frameworks. Home test kits range from digital test kits with app connectivity to reusable monitor kits and cost-effective strip-based options that prioritize ease of use. Lab services incorporate point-of-care testing services for near-patient diagnostics alongside reference lab services that support high-complexity assays and advanced analytics.

Based on technology, platforms are differentiated by digital imaging techniques, enzyme linked immunosorbent assay methodologies for quantitative biomarker detection, and lateral flow immunoassay approaches that enable rapid, qualitative results. Based on end user, the ecosystem serves diagnostic laboratories, fertility clinics, hospitals, and individual consumers, each with unique quality, regulatory, and data integration expectations. Recognizing these segmentation layers helps stakeholders prioritize product development, distribution models, and clinical engagement strategies tailored to the specific demands of each cohort.

Regional dynamics and market-entry imperatives that determine clinical adoption, reimbursement, and distribution strategies across major global territories

Regional dynamics shape clinical pathways, regulatory expectations, and commercial priorities across the fertility testing landscape. In the Americas, markets are characterized by a high degree of private-sector innovation, strong direct-to-consumer engagement, mature payer discussions, and an emphasis on integrated digital solutions that link home testing with telehealth and clinic follow-up. These factors create fertile ground for subscription-based monitoring services and partnerships between diagnostic developers and care networks.

Across Europe, the Middle East & Africa, regulatory harmonization, public healthcare procurement frameworks, and diverse access models influence how fertility tests are adopted. In many markets, reimbursement mechanisms and centralized procurement shape supplier selection, while countries with advanced genetics infrastructures are accelerating the integration of carrier and preconception screening into routine care. In contrast, regions with constrained laboratory capacity are prioritizing robust point-of-care solutions and simpler, high-value diagnostic tools that reduce referral burdens.

In the Asia-Pacific region, rapid digital adoption, sizable consumer markets, and expanding private healthcare sectors are driving growth in home testing and hybrid care models. Local manufacturing initiatives and regional supply-chain investments are also influencing product availability and cost structures. Collectively, these regional nuances highlight the need for market-entry strategies that balance regulatory compliance, distribution partnerships, and culturally appropriate patient engagement to maximize uptake and clinical impact.

Competitive differentiation through clinical validation, digital integration, strategic partnerships, and adaptive manufacturing approaches

Leading companies operating in fertility testing are differentiating along multiple dimensions: platform breadth, depth of clinical validation, digital integration, and channel partnerships. Some firms invest heavily in expanding laboratory capabilities and reference services to support complex genetic and hormone assays, while others focus on consumer-centric design to scale home test kits with seamless app-based interpretation. Across the competitive set, successful players balance rigorous analytical performance with clear clinical utility and user experience that reduces friction for both patients and providers.

Strategic collaborations between diagnostics developers, fertility clinics, and digital health platforms are becoming more common as companies seek to embed testing within longitudinal care pathways. Partnerships that enable bundled service offerings-combining initial screening, confirmatory laboratory testing, and clinician-led follow-up-are proving effective at driving adherence and generating richer outcome data. Additionally, M&A and licensing activity is reshaping capability stacks, with acquisitions frequently aimed at adding assay expertise, digital engagement tools, or regulatory footholds in target markets.

Companies prioritizing open data architectures and interoperability are positioning themselves to win in an environment where integrated care and outcome measurement matter. Finally, those with modular product roadmaps and flexible manufacturing strategies can react more nimbly to tariff pressures, supply chain disruptions, and changing reimbursement landscapes, thereby maintaining continuity of supply and preserving clinician and patient trust.

Practical imperatives for leaders to strengthen evidence, enable modular product design, secure supply resilience, and integrate diagnostics into care pathways

Industry leaders should prioritize a set of pragmatic actions that enhance resilience, accelerate adoption, and protect clinical integrity. First, invest in dual-pathway clinical evidence that demonstrates both analytical validity and real-world clinical utility across settings ranging from point of care to reference labs; such evidence supports payer conversations and clinician confidence. Next, design product portfolios with modular hardware and software components to enable rapid product reconfiguration and minimize exposure to tariff and component shortages.

Simultaneously, deepen partnerships with fertility clinics, diagnostic laboratories, and telehealth providers to create end-to-end patient journeys that reduce abandonment and improve diagnostic-to-treatment conversion. Align commercial models with outcomes by piloting bundled services and subscription monitoring to capture lifetime patient value and encourage adherence. Strengthen procurement and supplier management by implementing total landed cost analytics and multi-source strategies to mitigate single-supplier risk and customs-driven delays.

Finally, prioritize data governance, interoperability, and clinician-facing decision support so that test results translate into actionable care plans. By focusing on evidence generation, modular design, strategic partnerships, procurement sophistication, and data integration, industry leaders can convert market complexity into competitive advantage and sustained clinical impact.

Rigorous multi-method research approach combining primary stakeholder interviews, secondary clinical and regulatory synthesis, and transparent data triangulation

The research underpinning this executive summary is built on a multi-method approach that integrates primary qualitative interviews, secondary literature synthesis, and cross-validation with subject-matter experts. Primary inputs included structured interviews with clinicians, diagnostic laboratory directors, procurement leaders, and digital health executives to capture front-line perspectives on adoption barriers, workflow integration, and unmet clinical needs. Secondary analysis synthesized regulatory guidance, product technical specifications, and peer-reviewed literature to ensure analytical assertions were grounded in verifiable technical and clinical standards.

Data triangulation was employed to reconcile differing stakeholder viewpoints and identify robust themes. Where quantitative datasets were incorporated, care was taken to validate sources and ensure appropriate interpretation without projecting forward-looking estimates. The methodology emphasizes transparency of assumptions, clear documentation of data provenance, and a candid assessment of limitations, including potential regional heterogeneity and variability in clinical practice patterns. Ethical considerations and data privacy standards guided engagement protocols for interviews and the handling of any de-identified clinical datasets.

Finally, the research process prioritized actionable insight over descriptive reporting, using iterative synthesis to transform evidence into strategic recommendations that are relevant to commercial, clinical, and policy stakeholders operating in the fertility testing domain.

Synthesis of strategic priorities highlighting the need for evidence-based innovation, interoperable systems, and operational resilience to accelerate clinical adoption

The fertility testing domain is at an inflection point where technological maturation, changing patient expectations, and evolving commercial models converge to create new opportunities and responsibilities for stakeholders. Diagnostics developers and service providers must navigate an increasingly hybrid environment in which home-based monitoring complements laboratory-grade assays, and where data integration underpins clinical decision-making. As a result, the pathways by which tests are delivered, interpreted, and acted upon are changing, requiring coordinated responses across product development, clinical validation, and commercial channels.

Stakeholders who invest in rigorous evidence generation, prioritize interoperability, and structure partnerships with clinical care providers will be best placed to demonstrate value and secure long-term adoption. Equally important is the need for operational resilience in the face of supply chain and tariff pressures, which underscores the importance of procurement sophistication and flexible manufacturing strategies. Ultimately, the field will progress most effectively when innovations are paired with robust clinical governance and patient-centered design, ensuring that diagnostic advancements translate into improved reproductive health outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing use of AI-driven hormonal profiling platforms for personalized fertility assessments
  • 5.2. Expansion of at-home comprehensive fertility test kits integrating digital health platforms
  • 5.3. Surging demand for male fertility testing solutions driven by rising awareness of male infertility factors
  • 5.4. Integration of genetic screening and preconception carrier tests in standard fertility workups
  • 5.5. Emergence of microbiome analysis tests to assess reproductive tract health and optimize fertility
  • 5.6. Adoption of telehealth fertility consultations linked with home-based sample collection services
  • 5.7. Development of wearable biosensor devices for continuous hormone monitoring during fertility cycles
  • 5.8. Blockchain-based data security solutions ensuring privacy in direct-to-consumer fertility testing
  • 5.9. Increased collaboration between fertility clinics and digital therapeutics providers for holistic care
  • 5.10. Regulatory shifts streamlining approval processes for innovative fertility diagnostic technologies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fertility Testing Market, by Type

  • 8.1. Hormone Test
  • 8.2. Ovulation Test
  • 8.3. Pregnancy Test
  • 8.4. Sperm Quality Test

9. Fertility Testing Market, by Product

  • 9.1. Clinic Based Tests
    • 9.1.1. Hormone Panel Tests
    • 9.1.2. In-Clinic Ovulation Tests
    • 9.1.3. In-Clinic Pregnancy Tests
  • 9.2. Genetic Tests
    • 9.2.1. Carrier Screening
    • 9.2.2. Preconception Genetic Tests
  • 9.3. Home Test Kits
    • 9.3.1. Digital Test Kits
    • 9.3.2. Reusable Monitor Kits
    • 9.3.3. Strip Based Test Kits
  • 9.4. Lab Services
    • 9.4.1. Point Of Care Testing Services
    • 9.4.2. Reference Lab Services

10. Fertility Testing Market, by Technology

  • 10.1. Digital Imaging
  • 10.2. Enzyme Linked Immunosorbent Assay
  • 10.3. Lateral Flow Immunoassay

11. Fertility Testing Market, by End User

  • 11.1. Diagnostic Laboratories
  • 11.2. Fertility Clinics
  • 11.3. Hospitals
  • 11.4. Individuals

12. Fertility Testing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fertility Testing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fertility Testing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. The Procter & Gamble Company
    • 15.3.2. F. Hoffmann-La Roche AG
    • 15.3.3. CooperSurgical, Inc.
    • 15.3.4. Siemens Healthineers AG
    • 15.3.5. Thermo Fisher Scientific Inc.
    • 15.3.6. Quest Diagnostics Incorporated
    • 15.3.7. Laboratory Corporation of America Holdings
    • 15.3.8. Merck KGaA
    • 15.3.9. QIAGEN N.V.
    • 15.3.10. Abbott Laboratories

LIST OF FIGURES

  • FIGURE 1. GLOBAL FERTILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. FERTILITY TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. FERTILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FERTILITY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FERTILITY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FERTILITY TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FERTILITY TESTING MARKET SIZE, BY OVULATION TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FERTILITY TESTING MARKET SIZE, BY PREGNANCY TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FERTILITY TESTING MARKET SIZE, BY SPERM QUALITY TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FERTILITY TESTING MARKET SIZE, BY HORMONE PANEL TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC OVULATION TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FERTILITY TESTING MARKET SIZE, BY IN-CLINIC PREGNANCY TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FERTILITY TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FERTILITY TESTING MARKET SIZE, BY PRECONCEPTION GENETIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FERTILITY TESTING MARKET SIZE, BY REUSABLE MONITOR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FERTILITY TESTING MARKET SIZE, BY STRIP BASED TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FERTILITY TESTING MARKET SIZE, BY POINT OF CARE TESTING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FERTILITY TESTING MARKET SIZE, BY REFERENCE LAB SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FERTILITY TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FERTILITY TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL FERTILITY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL FERTILITY TESTING MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL FERTILITY TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL FERTILITY TESTING MARKET SIZE, BY INDIVIDUALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY LAB SERVICES, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC FERTILITY TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN FERTILITY TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN FERTILITY TESTING MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN FERTILITY TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 325. ASEAN FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2018-2024 (USD MILLION)
  • TABLE 326. ASEAN FERTILITY TESTING MARKET SIZE, BY CLINIC BASED TESTS, 2025-2032 (USD MILLION)
  • TABLE 327. ASEAN FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 328. ASEAN FERTILITY TESTING MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 329. ASEAN FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2018-2024 (USD MILLION)
  • TABLE 330. ASEAN FERTILITY TESTING MARKET SIZE, BY HOME TEST KITS, 2025-2032 (USD MILLION)
  • TABLE 331. ASEAN FER